{"component": "definition", "props": {"groups": [{"snippet": "means the ability of a method to measure analyte(s) in the presence of components which may be expected to be present.", "snippet_links": [{"key": "in-the-presence-of", "type": "definition", "offset": [52, 70]}], "size": 11, "samples": [{"hash": "ftVm6MAfDKB", "uri": "https://app.leg.wa.gov/WAC/default.aspx?cite=16-309-020&pdf=true", "label": "app.leg.wa.gov", "score": 18.9134883881, "published": false}, {"hash": "a20xQhjMevZ", "uri": "https://lawfilesext.leg.wa.gov/law/wsr/2024/09/24-09PERM.pdf", "label": "lawfilesext.leg.wa.gov", "score": 18.8649559021, "published": false}, {"hash": "hAyU0KtSfg7", "uri": "https://lawfilesext.leg.wa.gov/law/wsrpdf/2024/06/24-05-079.pdf", "label": "lawfilesext.leg.wa.gov", "score": 18.7775001526, "published": false}], "hash": "674c3f9c1c94677dcfc36d7719f699b4", "id": 1}, {"snippet": "means information on the petition for", "snippet_links": [{"key": "information-on", "type": "clause", "offset": [6, 20]}, {"key": "the-petition", "type": "clause", "offset": [21, 33]}], "size": 5, "samples": [{"hash": "2YQh6Uhfp0U", "uri": "https://flsenate.gov/Session/Bill/2017/7085/Amendment/655850/PDF", "label": "flsenate.gov", "score": 10.3395309448, "published": false}, {"hash": "lytdPxqwuBX", "uri": "https://flsenate.gov/Session/Bill/2017/7085/Amendment/841832/PDF", "label": "flsenate.gov", "score": 10.2196989059, "published": false}, {"hash": "kCFdjr2RZ5b", "uri": "https://static-s3.lobbytools.com/bills/2018/pdf/7009.pdf", "label": "static-s3.lobbytools.com", "score": 6.9383983612, "published": false}], "hash": "97edbc960d8ea28edb6d47afb5616f20", "id": 2}, {"snippet": "means the true negative rate (i.e., the proportion of subjects with an actual negative outcome who are correctly given a negative assignment).", "snippet_links": [{"key": "negative-rate", "type": "definition", "offset": [15, 28]}, {"key": "negative-outcome", "type": "definition", "offset": [78, 94]}], "size": 2, "samples": [{"hash": "4s2nyVmvNCF", "uri": "/contracts/4s2nyVmvNCF#specificity", "label": "Collaboration and License Agreement (Freenome Holdings, Inc.)", "score": 37.3203285421, "published": true}, {"hash": "4uRP4DrYnpv", "uri": "/contracts/4uRP4DrYnpv#specificity", "label": "Collaboration and License Agreement (Freenome Holdings, Inc.)", "score": 37.0301163587, "published": true}], "hash": "7a446ec6264e2be1c85472065f5fb87a", "id": 3}, {"snippet": "choosing the right type of activities that specifically match your activity goal. For example, if you want to improve how many push-ups you do, you need to build the muscles in your arms and chest, not legs. \u2022 Progression: increase the frequency, intensity and/or duration over periods of time in order to improve. In other words, how are you going to change the way you do your activities from Week 1 to Week 2 in order to make them more challenging. \u2022 Overload: work hard enough and long enough at intensity levels that overload your body, above resting conditions to bring about improvement. For example, if you can lift 10lb. weights pretty easily for a long time, then you probably should lift a weight that causes you to struggle slightly.", "snippet_links": [{"key": "the-right", "type": "clause", "offset": [9, 18]}, {"key": "of-activities", "type": "clause", "offset": [24, 37]}, {"key": "for-example", "type": "clause", "offset": [82, 93]}, {"key": "you-need", "type": "clause", "offset": [144, 152]}, {"key": "periods-of-time", "type": "clause", "offset": [278, 293]}, {"key": "in-order-to", "type": "clause", "offset": [294, 305]}, {"key": "your-activities", "type": "definition", "offset": [374, 389]}, {"key": "week-1", "type": "definition", "offset": [395, 401]}, {"key": "week-2", "type": "definition", "offset": [405, 411]}, {"key": "conditions-to", "type": "clause", "offset": [556, 569]}, {"key": "a-long", "type": "clause", "offset": [656, 662]}], "size": 2, "samples": [{"hash": "lAqdfc8Bxe7", "uri": "/contracts/lAqdfc8Bxe7#specificity", "label": "Personal Fitness Plan Contract", "score": 27.2121829987, "published": true}, {"hash": "jXYaWBwBMuR", "uri": "/contracts/jXYaWBwBMuR#specificity", "label": "Personal Fitness Plan Contract", "score": 26.8863792419, "published": true}], "hash": "eb3055695fee3432892a28c742290748", "id": 4}, {"snippet": "means that the monoclonal antibodies of the MATERIALS have are specific for mannitol-VGG in a manner consistent with that described in U.S. Patent No. 5,484,735 to \u2587\u2587\u2587\u2587\u2587 et al. and that such monoclonal antibodies will not cross react with non-glucosylated hemoglobin (Hb(Ac)) or with non-reduced glucosylated hemoglobin (Hb(A1c)).", "snippet_links": [{"key": "monoclonal-antibodies", "type": "definition", "offset": [15, 36]}, {"key": "the-materials", "type": "definition", "offset": [40, 53]}, {"key": "consistent-with", "type": "definition", "offset": [101, 116]}, {"key": "patent-no", "type": "clause", "offset": [140, 149]}], "size": 2, "samples": [{"hash": "9Itam6iP0pq", "uri": "/contracts/9Itam6iP0pq#specificity", "label": "Material Transfer and Option Agreement (Immtech International Inc)", "score": 18.0, "published": true}], "hash": "1c139c23463c6edef8869f8610900f3e", "id": 5}, {"snippet": ", in relation to a device, means how often the device correctly generates a negative result.\u201d.", "snippet_links": [{"key": "in-relation-to", "type": "clause", "offset": [2, 16]}, {"key": "the-device", "type": "clause", "offset": [43, 53]}, {"key": "negative-result", "type": "definition", "offset": [76, 91]}], "size": 2, "samples": [{"hash": "aGtdUnnPdhr", "uri": "https://www.legislation.gov.uk/uksi/2021/38/made/data.pdf", "label": "www.legislation.gov.uk", "score": 10.6878852844, "published": false}], "hash": "eea58ae36cf91df3e4371020760d960c", "id": 6}, {"snippet": "means information on the Petition For Benefits sufficient to put the employer or carrier on notice of the exact statutory classification and outstanding time period of benefits being requested and a detailed explanation of any benefits received that should be increased, decreased, changed, or otherwise modified. If for medical benefits, the specific details as to why such benefit is being requested; why such benefit is medically necessary, and why current treatment, if any, is not sufficient;", "snippet_links": [{"key": "information-on", "type": "clause", "offset": [6, 20]}, {"key": "petition-for-benefits", "type": "definition", "offset": [25, 46]}, {"key": "the-employer", "type": "definition", "offset": [65, 77]}, {"key": "notice-of-the", "type": "clause", "offset": [92, 105]}, {"key": "period-of-benefits", "type": "clause", "offset": [158, 176]}, {"key": "benefits-received", "type": "clause", "offset": [227, 244]}, {"key": "otherwise-modified", "type": "clause", "offset": [294, 312]}, {"key": "medical-benefits", "type": "definition", "offset": [321, 337]}, {"key": "specific-details", "type": "clause", "offset": [343, 359]}, {"key": "medically-necessary", "type": "definition", "offset": [423, 442]}], "size": 1, "samples": [{"hash": "cfNxAoKasOM", "uri": "https://aif.com/information/2003/extra/03wcbill.pdf", "label": "aif.com", "score": 6.5412502289, "published": false}], "hash": "80c08385c3be108955274ba6f9a9d7ae", "id": 7}, {"snippet": "selective versus family members and cross reactive with murine and macaca targets. Competes with control mAb provided", "snippet_links": [{"key": "family-members", "type": "definition", "offset": [17, 31]}], "size": 1, "samples": [{"hash": "bI66N47pDgt", "uri": "/contracts/bI66N47pDgt#specificity", "label": "Development and Option Agreement (Coherus BioSciences, Inc.)", "score": 35.2012329102, "published": true}], "hash": "d00fd6db5c70d1d29901788e39a5fa24", "id": 8}, {"snippet": "means the ability of the analytical procedure to unambiguously evaluate a defined substance independently of the other substances (impurities, degradation products, excipients, matrix (medium), etc.) present in the test sample;", "snippet_links": [{"key": "analytical-procedure", "type": "definition", "offset": [25, 45]}, {"key": "other-substances", "type": "definition", "offset": [113, 129]}, {"key": "test-sample", "type": "definition", "offset": [215, 226]}], "size": 1, "samples": [{"hash": "gCNUDvmtjXT", "uri": "http://www.pharm.am/attachments/article/5862/Decision%20EEC%20N113%202018.pdf", "label": "www.pharm.am", "score": 10.2936344147, "published": false}], "hash": "d78a1718c5db8e57aea7e3673618a7be", "id": 9}, {"snippet": "means the true negative rate or the percentage probability of a negative test result identifying a patient without a condition as compared to the gold standard test, which in our case is an echo.", "snippet_links": [{"key": "negative-rate", "type": "definition", "offset": [15, 28]}, {"key": "the-percentage", "type": "definition", "offset": [32, 46]}, {"key": "negative-test-result", "type": "definition", "offset": [64, 84]}, {"key": "standard-test", "type": "clause", "offset": [151, 164]}], "size": 1, "samples": [{"hash": "eNO8y7EB9EN", "uri": "http://pdf.secdatabase.com/2435/0001193125-22-260315.pdf", "label": "pdf.secdatabase.com", "score": 11.3449687958, "published": false}], "hash": "60022ea4c11e95bd6acbaeea36473799", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUc3BlY2lmaWNpdHkjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means the ability of a method to measure analyte(s) in the presence of components which may be expected to be present.", "size": 30, "title": "Specificity", "id": "specificity", "examples": ["<strong>Specificity</strong> The commission agreement should specify the commission rate and how your revenue share is structured."], "related": [["detail", "Detail", "Detail"], ["particulars", "Particulars", "Particulars"], ["reasonable-grounds", "Reasonable grounds", "Reasonable grounds"], ["nonconformity", "Nonconformity", "Nonconformity"], ["claims-notice", "Claims Notice", "Claims Notice"]], "related_snippets": [], "updated": "2026-04-30T06:05:53+00:00"}, "json": true, "cursor": ""}}